EQT PARTNERS invests in OTTOBOCK
Context
EQT VII has entered into an agreement to acquire a 20% minority stake in Ottobock, as part of a strategic partnership aimed at supporting Ottobock's international growth ambitions, driving its strategic objectives, and potentially preparing the company for a future initial public offering (IPO) in the medium term. The investment by EQT comes at a time of significant transformation in the mobility technology market, driven by an aging population, increasing demand for rehabilitation solutions, and advancements in smart prosthetics. This partnership enables Ottobock to secure a long-term financial partner while maintaining its majority family ownership. EQT brings its expertise in transforming industrial companies and driving international growth, with a focus on operational improvement and commercial acceleration. The transaction is subject to customary regulatory approvals and is part of a broader strategy to develop the group into a global leader in human mobility solutions.
OTTOBOCK, which reported an EBITDA margin of in 2016, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Ottobock is the global market leader in wearable human bionics and prosthetics. Its business model integrates the development and manufacturing of high-tech mobility solutions—including bionic prostheses, braces, and wheelchairs—with a vast global "Patient Care" network of over 400 fitting centers. The company’s value proposition centers on restoring human mobility through innovation, such as the microprocessor-controlled C-Leg and the Genium bionic knee. Strategically, Ottobock operates a vertically integrated model, capturing value from R&D and component manufacturing to direct clinical service delivery. With over 9,300 employees, the firm has evolved from a traditional family business into a data-driven medtech powerhouse, focusing on digitalizing the orthopedic fitting process and expanding its presence in emerging markets.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Other operations with OTTOBOCK
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 10/2025 | PUBLIC MARKETS (IPO) | OTTOBOCK | GERMANY | Implants & Prosthetics |
| 05/2025 | OTTOBOCK | MATTON ORTHOMEDI | BELGIUM | Implants & Prosthetics |
REFERENCES
Valuation range: EV 3b - 100b EUR
Revenue range: 450M - 900M EUR
EBITDA range: 100M - 200M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of OTTOBOCK by EQT PARTNERS are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Target: ottobock
Acquirer: eqt partners